<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d245">
    <sentence id="DDI-DrugBank.d245.s0" text="The hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.">
        <entity id="DDI-DrugBank.d245.s0.e0" charOffset="27-38"
            type="group" text="sulfonylurea"/>
        <entity id="DDI-DrugBank.d245.s0.e1" charOffset="86-122"
            type="group" text="nonsteroidal anti-inflammatory agents"/>
        <entity id="DDI-DrugBank.d245.s0.e2" charOffset="171-181"
            type="group" text="salicylates"/>
        <entity id="DDI-DrugBank.d245.s0.e3" charOffset="184-195"
            type="group" text="sulfonamides"/>
        <entity id="DDI-DrugBank.d245.s0.e4" charOffset="198-212"
            type="drug" text="chloramphenicol"/>
        <entity id="DDI-DrugBank.d245.s0.e5" charOffset="215-224"
            type="drug" text="probenecid"/>
        <entity id="DDI-DrugBank.d245.s0.e6" charOffset="227-235"
            type="group" text="coumarins"/>
        <entity id="DDI-DrugBank.d245.s0.e7" charOffset="238-265"
            type="group" text="monoamine oxidase inhibitors"/>
        <entity id="DDI-DrugBank.d245.s0.e8" charOffset="272-302"
            type="group" text="beta adrenergic blocking agents"/>
        <ddi id="DDI-DrugBank.d245.s0.d0" e1="DDI-DrugBank.d245.s0.e0"
            e2="DDI-DrugBank.d245.s0.e1" type="effect"/>
        <ddi id="DDI-DrugBank.d245.s0.d1" e1="DDI-DrugBank.d245.s0.e0"
            e2="DDI-DrugBank.d245.s0.e2" type="effect"/>
        <ddi id="DDI-DrugBank.d245.s0.d2" e1="DDI-DrugBank.d245.s0.e0"
            e2="DDI-DrugBank.d245.s0.e3" type="effect"/>
        <ddi id="DDI-DrugBank.d245.s0.d3" e1="DDI-DrugBank.d245.s0.e0"
            e2="DDI-DrugBank.d245.s0.e4" type="effect"/>
        <ddi id="DDI-DrugBank.d245.s0.d4" e1="DDI-DrugBank.d245.s0.e0"
            e2="DDI-DrugBank.d245.s0.e5" type="effect"/>
        <ddi id="DDI-DrugBank.d245.s0.d5" e1="DDI-DrugBank.d245.s0.e0"
            e2="DDI-DrugBank.d245.s0.e6" type="effect"/>
        <ddi id="DDI-DrugBank.d245.s0.d6" e1="DDI-DrugBank.d245.s0.e0"
            e2="DDI-DrugBank.d245.s0.e7" type="effect"/>
        <ddi id="DDI-DrugBank.d245.s0.d7" e1="DDI-DrugBank.d245.s0.e0"
            e2="DDI-DrugBank.d245.s0.e8" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d245.s1" text="When such drugs are administered to a patient receiving DIABINESE, the patient should be observed closely for hypoglycemia.">
        <entity id="DDI-DrugBank.d245.s1.e0" charOffset="56-64"
            type="brand" text="DIABINESE"/>
    </sentence>
    <sentence id="DDI-DrugBank.d245.s2" text="When such drugs are withdrawn from a patient receiving DIABINESE, the patient should be observed closely for loss of control.">
        <entity id="DDI-DrugBank.d245.s2.e0" charOffset="55-63"
            type="brand" text="DIABINESE"/>
    </sentence>
    <sentence id="DDI-DrugBank.d245.s3" text="Certain drugs tend to produce hyperglycemia and may lead to loss of control."/>
    <sentence id="DDI-DrugBank.d245.s4" text="These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.">
        <entity id="DDI-DrugBank.d245.s4.e0" charOffset="24-32"
            type="group" text="thiazides"/>
        <entity id="DDI-DrugBank.d245.s4.e1" charOffset="44-52"
            type="group" text="diuretics"/>
        <entity id="DDI-DrugBank.d245.s4.e2" charOffset="55-69"
            type="group" text="corticosteroids"/>
        <entity id="DDI-DrugBank.d245.s4.e3" charOffset="72-85"
            type="group" text="phenothiazines"/>
        <entity id="DDI-DrugBank.d245.s4.e4" charOffset="106-114"
            type="group" text="estrogens"/>
        <entity id="DDI-DrugBank.d245.s4.e5" charOffset="122-135"
            type="group" text="contraceptives"/>
        <entity id="DDI-DrugBank.d245.s4.e6" charOffset="138-146"
            type="drug" text="phenytoin"/>
        <entity id="DDI-DrugBank.d245.s4.e7" charOffset="149-162"
            type="drug" text="nicotinic acid"/>
        <entity id="DDI-DrugBank.d245.s4.e8" charOffset="165-180"
            type="group" text="sympathomimetics"/>
        <entity id="DDI-DrugBank.d245.s4.e9" charOffset="183-212"
            type="group" text="calcium channel blocking drugs"/>
        <entity id="DDI-DrugBank.d245.s4.e10" charOffset="219-227"
            type="drug" text="isoniazid"/>
    </sentence>
    <sentence id="DDI-DrugBank.d245.s5" text="When such drugs are administered to a patient receiving DIABINESE, the patient should be closely observed for loss of control.">
        <entity id="DDI-DrugBank.d245.s5.e0" charOffset="56-64"
            type="brand" text="DIABINESE"/>
    </sentence>
    <sentence id="DDI-DrugBank.d245.s6" text="When such drugs are withdrawn from a patient receiving DIABINESE, the patient should be observed closely for hypoglycemia.">
        <entity id="DDI-DrugBank.d245.s6.e0" charOffset="55-63"
            type="brand" text="DIABINESE"/>
    </sentence>
    <sentence id="DDI-DrugBank.d245.s7" text="Since animal studies suggest that the action of barbiturates may be prolonged by therapy with chlorpropamide, barbiturates should be employed with caution.">
        <entity id="DDI-DrugBank.d245.s7.e0" charOffset="48-59"
            type="group" text="barbiturates"/>
        <entity id="DDI-DrugBank.d245.s7.e1" charOffset="94-107"
            type="drug" text="chlorpropamide"/>
        <entity id="DDI-DrugBank.d245.s7.e2" charOffset="110-121"
            type="group" text="barbiturates"/>
        <ddi id="DDI-DrugBank.d245.s7.d0" e1="DDI-DrugBank.d245.s7.e0"
            e2="DDI-DrugBank.d245.s7.e1" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d245.s8" text="In some patients, a disulfiram-like reaction may be produced by the ingestion of alcohol.">
        <entity id="DDI-DrugBank.d245.s8.e0" charOffset="20-29"
            type="drug" text="disulfiram"/>
        <entity id="DDI-DrugBank.d245.s8.e1" charOffset="81-87"
            type="drug" text="alcohol"/>
    </sentence>
    <sentence id="DDI-DrugBank.d245.s9" text="A potential interaction between oral miconazole and oral hypoglycemic agents leading to severe hypoglycemia has been reported.">
        <entity id="DDI-DrugBank.d245.s9.e0" charOffset="37-46"
            type="drug" text="miconazole"/>
        <entity id="DDI-DrugBank.d245.s9.e1" charOffset="57-75"
            type="group" text="hypoglycemic agents"/>
        <ddi id="DDI-DrugBank.d245.s9.d0" e1="DDI-DrugBank.d245.s9.e0"
            e2="DDI-DrugBank.d245.s9.e1" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d245.s10" text="Whether this interaction also occurs with the intravenous, topical, or vaginal preparations of miconazole is not known.">
        <entity id="DDI-DrugBank.d245.s10.e0" charOffset="95-104"
            type="drug" text="miconazole"/>
    </sentence>
</document>
